Mirena Does Not Cause or Worsen Lumbar Disc Herniation
There is no established causal relationship between the levonorgestrel-releasing intrauterine system (Mirena) and lumbar disc herniation, and it can be safely continued for contraception in patients with this condition.
No Biological Plausibility or Evidence
The provided evidence contains no data linking Mirena or any levonorgestrel-releasing IUD to disc herniation or spinal pathology. Lumbar disc herniation results from mechanical degeneration of the intervertebral disc, influenced by genetics, weight, occupational factors, smoking, and sedentary lifestyle 1. These are entirely distinct from the local uterine effects and systemic hormonal actions of the LNG-IUS.
Safety Profile Supports Continuation
The most recent guidelines and research demonstrate that:
- LNG-IUS has minimal systemic effects - The device releases levonorgestrel locally within the uterus with minimal systemic absorption
- No musculoskeletal contraindications exist - Current guidelines 2 list no musculoskeletal or spinal conditions as contraindications to LNG-IUS use
- Bone health is preserved or improved - Studies show bone mineral density actually increases with LNG-IUS use (+2.40% lumbar spine, +3.34% BMC over 12 months) 3, contrasting with bone loss seen with depot medroxyprogesterone acetate
Medical Eligibility Criteria
According to established guidelines 4, LNG-IUS is contraindicated (Category 4) only for:
- Distorted uterine cavity
- Current breast cancer
- Cervical or endometrial cancer
- Active pelvic infection
- Unexplained vaginal bleeding
- Malignant gestational trophoblastic disease
Lumbar disc herniation is not listed as any category of restriction.
Clinical Recommendation
Continue the Mirena without modification. The patient's disc herniation should be managed according to standard orthopedic/neurosurgical protocols 1, 5, which typically involve:
- Conservative management for 6-12 weeks (NSAIDs, physical therapy) for most cases
- Immediate surgical evaluation only for cauda equina syndrome or rapidly progressive neurological deficits (<24 hours)
- Surgical consideration after failed conservative therapy
The contraceptive method is entirely independent of disc pathology and should not be discontinued based on this diagnosis. Recent evidence confirms LNG-IUS safety and efficacy for up to 8 years 6, with satisfaction rates above 85% and very low complication rates.
Common Pitfall to Avoid
Do not attribute unrelated musculoskeletal symptoms to hormonal contraception without clear evidence. Patients may temporally associate their IUD with back pain simply because both exist concurrently, but correlation does not equal causation. The timing and mechanism of disc herniation are biomechanical, not hormonal.